Commentary on "Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples"

Alzheimer's and Dementia

Volumn 2, Issue 3, 2006, Pages 169-170

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BASAL GANGLION; BINSWANGER ENCEPHALOPATHY; BRAIN CORTEX; BRAIN STEM; DEMENTIA; DISEASE SEVERITY; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY; MULTIINFARCT DEMENTIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SILVER STAINING; VALIDATION STUDY;

EID: 33744944535     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2006.03.005     Document Type: Note

References (11)

1. Plassman B.L., Khachaturian A.S., Townsend J.J., Ball M.J., Steffens D.C., Leslie C.E., et al. Comparison of clinical and neuropathologic diagnosis of Alzheimer's disease in 3 epidemiologic samples. Alzheimer's & Dementia 2 (2006) 2-11
2. Bancher C., Jellinger K., Lassmann H., Fischer P., and Leblhuber F. Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 246 (1996) 137-146
3. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
4. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82 (1991) 239-259
5. Hyman B.T., and Trojanowski J.Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56 (1997) 1095-1097
6. Jellinger K.A. Neuropathology of Alzheimer disease and clinical relevance. In: Iqbal K., and Winblad B. (Eds). Alzheimer's disease and related disorders. Research advances (2003), Ana Aslan Intl. Acad. of Aging, Bucharest, Romania 152-169
7. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
8. Jellinger K.A. Clinicopathological analysis of dementia disorders in the elderly-an update. J Alzheimer's Dis (2006) (in press)
9. Jellinger K.A. Plaque-predominant and tangle-predominant variants of Alzheimer's disease. In: Dickson D.W. (Ed). Neurodegeneration. The molecular pathology of dementia and movement disorders (2003), ISN Neuropath Press, Basel 66-68
10. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., et al. The Lewy body variant of Alzheimer's disease. A clinical and pathologic entity. Neurology 40 (1990) 1-8
11. Tiraboschi P., Sabbagh M.N., Hansen L.A., Salmon D.P., Merdes A., Gamst A., et al. Alzheimer disease without neocortical neurofibrillary tangles. "a second look.". Neurology 62 (2004) 1141-1147